Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients is a research paper published in Journal for ImmunoTherapy of Cancer (2023). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph â no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full â never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology âSwim Across America
Grant: N/A
National Cancer Institute
Grant: K08CA252642
National Cancer Institute
Grant: NCI-5K23CA178083
National Cancer Institute
Grant: NCI-F31CA250320
National Cancer Institute
Grant: P30 CA076292
American Cancer Society
Grant: RSG-16- 117-01-LIB
NCI NIH HHS
Grant: F31 CA250320
NCI NIH HHS
Grant: K23 CA178083
FWCI
4.16
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords